We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+20.42%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.1B
AUM Growth
+$380M
(+14%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-34.94%
Top 10 Holdings %
Top 10 Hldgs %
37.76%
Holding
89
New
16
Increased
13
Reduced
14
Closed
12
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
+$50.7M |
| 2 |
CG Oncology
CGON
|
+$46.2M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
+$42.3M |
| 4 |
Legend Biotech
LEGN
|
+$41.1M |
| 5 |
Transmedics
TMDX
|
+$40.9M |
Top Sells
| 1 |
Immunocore
IMCR
|
+$41.8M |
| 2 |
Lantheus
LNTH
|
+$30.7M |
| 3 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$30.6M |
| 4 |
Keros Therapeutics
KROS
|
+$22.6M |
| 5 |
Amgen
AMGN
|
+$16.8M |
Sector Composition
| 1 | Healthcare | 57.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kiniksa Pharmaceuticals
KNSA
$4.75B
| $27.5M | 0.89% |
+1,392,716
| New | +$27.2M |
|
27
Thermo Fisher Scientific
TMO
$199B
| $27.4M | 0.88% |
47,149
-28,600
| -38% | -$16M |
|
28
Repligen
RGEN
$8.35B
| $26.3M | 0.85% |
142,836
+40,138
| +39% | +$7.64M |
|
|
NVRO
29
DELISTED
NEVRO CORP.
NVRO
| $25.7M | 0.83% |
1,776,368
| – | – |
|
30
Inspire Medical Systems
INSP
$1.46B
| $21.8M | 0.7% |
101,492
-83,166
| -45% | -$16.3M |
|
31
Cullinan Oncology
CGEM
$1.1B
| $21.1M | 0.68% |
1,240,865
| – | – |
|
|
TRML
32
DELISTED
Tourmaline Bio
TRML
| $20.8M | 0.67% |
906,820
| – | – |
|
33
Lexeo Therapeutics
LXEO
$372M
| $20.7M | 0.67% |
+1,322,277
| New | +$20.7M |
|
34
Spyre Therapeutics
SYRE
$8.86B
| $19.5M | 0.63% |
515,000
| – | – |
|
35
BioMarin Pharmaceuticals
BMRN
$11.4B
| $19.1M | 0.62% |
+218,896
| New | +$19.6M |
|
36
Structure Therapeutics
GPCR
$3.53B
| $18.7M | 0.6% |
435,823
+155,665
| +56% | +$6.56M |
|
37
BioCryst Pharmaceuticals
BCRX
$2.39B
| $17.2M | 0.55% |
3,379,577
-2,338,900
| -41% | -$13.2M |
|
|
ITOS
38
DELISTED
iTeos Therapeutics
ITOS
| $15.9M | 0.51% |
+1,162,374
| New | +$12.7M |
|
39
Mineralys Therapeutics
MLYS
$2.41B
| $14.8M | 0.48% |
1,147,154
-876,746
| -43% | -$10.8M |
|
40
Alector
ALEC
$167M
| $14.3M | 0.46% |
2,380,704
-943,604
| -28% | -$6.17M |
|
41
Arcutis Biotherapeutics
ARQT
$3.47B
| $12.9M | 0.42% |
+1,300,000
| New | +$9.7M |
|
|
ELEV
42
DELISTED
Elevation Oncology
ELEV
| $12.2M | 0.39% |
+2,377,647
| New | +$7.7M |
|
43
BridgeBio Pharma
BBIO
$16.2B
| $10.7M | 0.34% |
+344,827
| New | +$11.7M |
|
44
Iovance Biotherapeutics
IOVA
$2.12B
| $9.78M | 0.32% |
+660,022
| New | +$7.68M |
|
|
DCPH
45
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $9.59M | 0.31% |
609,643
-559,847
| -48% | -$8.62M |
|
46
Olema Pharmaceuticals
OLMA
$1.03B
| $7.97M | 0.26% |
+704,344
| New | +$9.09M |
|
47
Pulmonx
LUNG
$60.8M
| $6.98M | 0.22% |
752,541
-35,413
| -4% | -$415K |
|
|
DBVT
48
DBV Technologies
DBVT
$930M
| $5.93M | 0.19% |
784,329
| – | – |
|
49
Outset Medical
OM
$84M
| $5.33M | 0.17% |
160,028
| – | – |
|
50
Adaptive Biotechnologies
ADPT
$916M
| $4.36M | 0.14% |
1,357,490
| – | – |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM